Published in Semin Cancer Biol on June 01, 1999
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol (2003) 2.20
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev (2002) 1.67
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J Virol (2009) 1.04
Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies. Clin Vaccine Immunol (2008) 1.03
Human herpesvirus 8--a novel human pathogen. Virol J (2005) 1.00
Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol (2001) 0.96
Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J Clin Microbiol (2002) 0.91
New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies. Clin Diagn Lab Immunol (2000) 0.85
Iron: a target for the management of Kaposi's sarcoma? BMC Cancer (2004) 0.85
Immune escape of γ-herpesviruses from adaptive immunity. Rev Med Virol (2014) 0.84
Prevalence of viremia and oral shedding of rhesus rhadinovirus and retroperitoneal fibromatosis herpesvirus in large age-structured breeding groups of rhesus macaques (Macaca mulatta). Comp Med (2009) 0.83
Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer (2003) 0.81
Localization of human herpesvirus type 8 in human sperms by in situ PCR. J Mol Histol (2006) 0.81
Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. Transl Biomed (2010) 0.79
Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells. Sarcoma (2000) 0.78
Laboratory diagnosis of human herpesvirus 8 infection in humans. Eur J Clin Microbiol Infect Dis (2002) 0.78
A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population. J Pediatric Infect Dis Soc (2013) 0.77
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. Br J Cancer (2002) 0.77
Human herpesvirus type 8 in tuberculosis patients with effusion. BMC Infect Dis (2015) 0.75
Angiosarcoma in HIV-negative patients is not associated with HHV-8. An Bras Dermatol (2017) 0.75
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med (1988) 2.81
HBLV (or HHV-6) in human cell lines. Nature (1987) 2.53
Genomic analysis of the human B-lymphotropic virus (HBLV). Science (1986) 2.23
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (1989) 1.96
Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A (1992) 1.85
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med (1992) 1.46
Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients. Int J Cancer (1975) 1.35
Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. Int J Cancer (1973) 1.34
Molecular studies of HHV-6. J Virol Methods (1988) 1.32
Diverse tropism of HBLV (human herpesvirus 6) Lancet (1987) 1.29
Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25
The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol (1990) 1.23
Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7. J Infect Dis (1992) 1.22
Antigenic relationships among human herpesvirus-6 isolates. J Med Virol (1992) 1.18
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes. J Virol (1991) 1.17
Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. Leukemia (1988) 1.17
Preparation of immune rabbit sera with neutralizing activity against human cytomegalovirus and varicella-zoster virus. J Gen Virol (1970) 1.15
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis (1994) 1.14
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol (1991) 1.11
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol (1992) 1.09
Malignant lymphoma with lymphocytic leukemia induced in owl monkeys by Herpesvirus saimiri. J Natl Cancer Inst (1971) 1.08
HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens. Int J Cancer (1987) 1.07
HHV-6 reactivation in chronic fatigue syndrome. Lancet (1991) 1.06
Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol (1993) 1.06
A repeat sequence, GGGTTA, is shared by DNA of human herpesvirus 6 and Marek's disease virus. J Virol (1988) 1.05
Human herpesvirus 6 (HHV6) and chronic fatigue syndrome (CFS). Can Dis Wkly Rep (1991) 1.05
Latent herpesvirus-6 in salivary and bronchial glands. Lancet (1990) 1.03
Differentiation of cross-reacting simian cytomegalovirus strains by late 19S rabbit neutralizing antibodies. J Immunol (1969) 1.02
Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol (1994) 1.00
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. J Virol Methods (1988) 0.99
Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA (1988) 0.98
Murine cytomegalovirus: induction of and sensitivity to interferon in vitro. Infect Immun (1975) 0.93
Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. J Immunol (1978) 0.92
Preparation of rabbit immune serum with neutralizing activity against a simian cytomegalovirus (SA6). J Immunol (1969) 0.92
Morphological studies on Herpesvirus saimiri in subhuman and human cell cultures. Cancer Res (1971) 0.92
Human B-lymphotropic virus in Germany. Lancet (1987) 0.92
Mixed culture cytopathogenicity induced by virus preparations derived from cultures infected by simian sarcoma virus. J Natl Cancer Inst (1972) 0.91
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol (2000) 0.89
Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems. Eur J Cancer (1977) 0.89
The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome. Ann Intern Med (1989) 0.89
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Human herpesvirus type 8 in salivary gland tumors. J Clin Virol (2000) 0.88
Active human herpesvirus-6 (HHV-6) infection associated with Kikuchi-Fujimoto disease and systemic lupus erythematosus (SLE). In Vivo (1991) 0.88
Experimental infection of Callithrix Jacchus marmosets with Herpesvirus ateles, Herpesvirus saimiri, and Epstein Barr virus. Biomedicine (1978) 0.88
Characteristics of Herpesvirus saimiri-induced lymphoma cells in tissue culture. In Vitro (1974) 0.88
Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. Anticancer Res (1990) 0.87
In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods (1988) 0.87
Human herpesvirus-6 and cross-reactivity with other herpesviruses. Lancet (1989) 0.86
Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers. J Natl Cancer Inst (1981) 0.86
Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica. J Natl Cancer Inst (1998) 0.85
HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus. Invest Ophthalmol Vis Sci (1995) 0.85
Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis. J Infect (2000) 0.84
Herpesvirus saimiri-induced lymphoblastoid rabbit cell line: growth characteristics, virus persistence, and oncogenic properties. J Virol (1985) 0.84
Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo (1991) 0.84
Human herpesvirus-6 infection may predispose cells to superinfection by other viruses. In Vivo (1991) 0.83
Propagation of Herpesvirus saimiri in human cells. J Natl Cancer Inst (1971) 0.83
Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results. Biomedicine (1973) 0.83
A chronic "postinfectious" fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6. J Clin Immunol (1990) 0.83
Infection by human herpesvirus 6 (HHV-6) of human lymphoid T cells occurs through an endocytic pathway. AIDS Res Hum Retroviruses (1992) 0.83
Characterization of murine Rauscher leukemia virus propagated in human cells. J Natl Cancer Inst (1972) 0.82
Persistent human herpesvirus 8 viremia associated with coinfection with human T-cell lymphotropic virus type I and myelofibrosis. J Acquir Immune Defic Syndr (2000) 0.82
Antibodies to human herpes virus-6 in patients with acute lymphocytic leukemia. Leukemia (1992) 0.82
Development and application of HHV-6 antigen capture assay for the detection of HHV-6 infections. J Virol Methods (1996) 0.81
Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer (1992) 0.81
A cytomegalovirus isolated from an owl monkey. Lab Anim Sci (1972) 0.81
Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells. Proc Natl Acad Sci U S A (1977) 0.81
Search for early lesions following human immunodeficiency virus type 1 infection. A study of six individuals who died a violent death after seroconversion. Arch Pathol Lab Med (1990) 0.81
Distribution of T- and B-cells and of immunoglobulin-producing cells in tumor tissue of patients with nasopharyngeal carcinoma. J Cancer Res Clin Oncol (1979) 0.81
Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Res (1981) 0.81
Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma. Anticancer Res (1990) 0.80
Correlation between the neutralizing activity of human serum against Herpes simplex virus and a simian herpesvirus (SA8). J Immunol (1969) 0.80
Electrophoretic analysis of human herpesvirus 6 polypeptides immunoprecipitated from infected cells with human sera. J Infect Dis (1991) 0.80
Morphologic studies of a cytomegalovirus isolated from an owl monkey. J Natl Cancer Inst (1972) 0.80
Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst (1999) 0.80
Clinical indications and diagnostic techniques of human herpesvirus-6 (HHV-6) infection. In Vivo (1991) 0.80
Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens. Int J Cancer (1977) 0.79
Steroids inhibit tumor promoting agent induced Epstein-Barr virus early antigens in Raji cells. Int J Cancer (1981) 0.79
Development of immunity to Epstein-Barr virus in Malaysian children. Microbiologica (1987) 0.79
Virological investigations of Herpesvirus saimiri-infected owl monkeys. J Med Primatol (1974) 0.79
Induction of lymphoma in owl monkeys with heated, non-cytopathogenic Herpesvirus saimiri. Nat New Biol (1973) 0.79
Chronic Herpesvirus saimiri infection in an owl monkey. J Natl Cancer Inst (1976) 0.79
Tumor promoting agent induces lymphocyte mitogenic factor. Biomedicine (1981) 0.78
Ultrastructural and biological properties of a cytomegalovirus rescued from a human paraganglioma. Cancer Res (1971) 0.78
Clinical correlates of infection with human herpesvirus-6. In Vivo (1995) 0.78
Frequent detection of human herpesvirus 6 in oral carcinoma. J Natl Cancer Inst (1994) 0.78
Multistage carcinogenesis utilizing human genital cells and human papillomaviruses. Toxicol Lett (1994) 0.78
Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients. Biomedicine (1974) 0.78
Replication of Herpesvirus saimiri is semipermissive in human cells because of a block in the synthesis of certain late proteins. Intervirology (1988) 0.78
Herpesviruses and cancer in man and subhuman primates. Biomedicine (1976) 0.78
Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response. Int J Cancer (1982) 0.78
Persistent fatigue and depression in patient with antibody to human B-lymphotropic virus. Lancet (1987) 0.78
Isolation of transforming Epstein-Barr virus from plasma of HTLV-III/LAV-infected patients. Intervirology (1987) 0.78
Immunological dysregulation of lymph nodes in AIDS patients. Curr Top Pathol (1991) 0.78
Diagnosis and differential diagnosis of progressive lymphoproliferation and malignant lymphoma in persistent active herpesvirus infection. J Virol Methods (1988) 0.78
Herpesvirus saimiri-induced malignant lymphoma in inbred strain III/J rabbits (Oryctolagus cuniculus). J Cancer Res Clin Oncol (1980) 0.78
Mitogenic effect of 12-0 tetradecanoyl phorbol 13-acetate on non-human primate mononuclear cells and in vitro interaction with Epstein-Barr virus transformation. Arch Virol (1980) 0.77